192 related articles for article (PubMed ID: 22525723)
1. Role of chemokine receptor CXCR7 in bladder cancer progression.
Hao M; Zheng J; Hou K; Wang J; Chen X; Lu X; Bo J; Xu C; Shen K; Wang J
Biochem Pharmacol; 2012 Jul; 84(2):204-14. PubMed ID: 22525723
[TBL] [Abstract][Full Text] [Related]
2. Chemokine receptor 7 targets the vascular endothelial growth factor via the AKT/ERK pathway to regulate angiogenesis in colon cancer.
Li X; Wang X; Li Z; Zhang Z; Zhang Y
Cancer Med; 2019 Sep; 8(11):5327-5340. PubMed ID: 31348616
[TBL] [Abstract][Full Text] [Related]
3. CXCR7 signaling induced epithelial-mesenchymal transition by AKT and ERK pathways in epithelial ovarian carcinomas.
Yu H; Zhang L; Liu P
Tumour Biol; 2015 Mar; 36(3):1679-83. PubMed ID: 25359618
[TBL] [Abstract][Full Text] [Related]
4. The chemokine receptor CXCR7 is a critical regulator for the tumorigenesis and development of papillary thyroid carcinoma by inducing angiogenesis in vitro and in vivo.
Zhang H; Yang L; Teng X; Liu Z; Liu C; Zhang L; Liu Z
Tumour Biol; 2016 Feb; 37(2):2415-23. PubMed ID: 26383519
[TBL] [Abstract][Full Text] [Related]
5. C-X-C motif chemokine ligand 12 (CXCL12)/C-X-C motif chemokine receptor 7(CXCR7) regulates epithelial-mesenchymal transition process and promotes the metastasis of esophageal cancer by activating signal transducer and activator of transcription 3 (STAT3) pathway.
Guo J; Tong CY; Shi JG; Li XJ
Bioengineered; 2022 Mar; 13(3):7425-7438. PubMed ID: 35264069
[TBL] [Abstract][Full Text] [Related]
6. CXCR7 silencing inhibits the migration and invasion of human tumor endothelial cells derived from hepatocellular carcinoma by suppressing STAT3.
Wu Y; Tian L; Xu Y; Zhang M; Xiang S; Zhao J; Wang Z
Mol Med Rep; 2018 Aug; 18(2):1644-1650. PubMed ID: 29901083
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of CXCR7 induces angiogenic capacity of human hepatocellular carcinoma cells via the AKT signaling pathway.
Chen Y; Teng F; Wang G; Nie Z
Oncol Rep; 2016 Oct; 36(4):2275-81. PubMed ID: 27572688
[TBL] [Abstract][Full Text] [Related]
8. C-X-C chemokine receptor 7: a functionally associated molecular marker for bladder cancer.
Yates TJ; Knapp J; Gosalbez M; Lokeshwar SD; Gomez CS; Benitez A; Ekwenna OO; Young EE; Manoharan M; Lokeshwar VB
Cancer; 2013 Jan; 119(1):61-71. PubMed ID: 22736438
[TBL] [Abstract][Full Text] [Related]
9. CAV-1 contributes to bladder cancer progression by inducing epithelial-to-mesenchymal transition.
Liang W; Hao Z; Han JL; Zhu DJ; Jin ZF; Xie WL
Urol Oncol; 2014 Aug; 32(6):855-63. PubMed ID: 24968949
[TBL] [Abstract][Full Text] [Related]
10. Decreased TRPM7 inhibits activities and induces apoptosis of bladder cancer cells via ERK1/2 pathway.
Cao R; Meng Z; Liu T; Wang G; Qian G; Cao T; Guan X; Dan H; Xiao Y; Wang X
Oncotarget; 2016 Nov; 7(45):72941-72960. PubMed ID: 27662662
[TBL] [Abstract][Full Text] [Related]
11. CXCR7 stimulates MAPK signaling to regulate hepatocellular carcinoma progression.
Lin L; Han MM; Wang F; Xu LL; Yu HX; Yang PY
Cell Death Dis; 2014 Oct; 5(10):e1488. PubMed ID: 25341042
[TBL] [Abstract][Full Text] [Related]
12. RUNX2 Plays An Oncogenic Role in Esophageal Carcinoma by Activating the PI3K/AKT and ERK Signaling Pathways.
Lu H; Jiang T; Ren K; Li ZL; Ren J; Wu G; Han X
Cell Physiol Biochem; 2018; 49(1):217-225. PubMed ID: 30138923
[TBL] [Abstract][Full Text] [Related]
13. CXCR7 mediates TGFβ1-promoted EMT and tumor-initiating features in lung cancer.
Wu YC; Tang SJ; Sun GH; Sun KH
Oncogene; 2016 Apr; 35(16):2123-32. PubMed ID: 26212008
[TBL] [Abstract][Full Text] [Related]
14. CXCR7 promotes melanoma tumorigenesis via Src kinase signaling.
Xu S; Tang J; Wang C; Liu J; Fu Y; Luo Y
Cell Death Dis; 2019 Feb; 10(3):191. PubMed ID: 30804329
[TBL] [Abstract][Full Text] [Related]
15. Combined application of anti-VEGF and anti-EGFR attenuates the growth and angiogenesis of colorectal cancer mainly through suppressing AKT and ERK signaling in mice model.
Ding C; Li L; Yang T; Fan X; Wu G
BMC Cancer; 2016 Oct; 16(1):791. PubMed ID: 27729020
[TBL] [Abstract][Full Text] [Related]
16. CXCR6 induces prostate cancer progression by the AKT/mammalian target of rapamycin signaling pathway.
Wang J; Lu Y; Wang J; Koch AE; Zhang J; Taichman RS
Cancer Res; 2008 Dec; 68(24):10367-76. PubMed ID: 19074906
[TBL] [Abstract][Full Text] [Related]
17. CXCL12-CXCR7 signaling activates ERK and Akt pathways in human choriocarcinoma cells.
Tripathi V; Kumar R; Dinda AK; Kaur J; Luthra K
Cell Commun Adhes; 2014 Aug; 21(4):221-8. PubMed ID: 24450273
[TBL] [Abstract][Full Text] [Related]
18. Biological/pathological functions of the CXCL12/CXCR4/CXCR7 axes in the pathogenesis of bladder cancer.
Nazari A; Khorramdelazad H; Hassanshahi G
Int J Clin Oncol; 2017 Dec; 22(6):991-1000. PubMed ID: 29022185
[TBL] [Abstract][Full Text] [Related]
19. CXCR7/p-ERK-Signaling Is a Novel Target for Therapeutic Vasculogenesis in Patients with Coronary Artery Disease.
Cao Z; Tong X; Xia W; Chen L; Zhang X; Yu B; Yang Z; Tao J
PLoS One; 2016; 11(9):e0161255. PubMed ID: 27612090
[TBL] [Abstract][Full Text] [Related]
20. Elevated Gab2 induces tumor growth and angiogenesis in colorectal cancer through upregulating VEGF levels.
Ding C; Luo J; Fan X; Li L; Li S; Wen K; Feng J; Wu G
J Exp Clin Cancer Res; 2017 Apr; 36(1):56. PubMed ID: 28420432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]